The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation. Academic Article uri icon

Overview

abstract

  • Patients with advanced non-seminomatous germ cell tumors may achieve a serologic and radiographic complete response (CR) to first-line chemotherapy (defined as a residual mass < 1 cm in size). Recent reports suggest that these patients may be observed with a low rate of relapse but there remain compelling arguments for surgical excision. The arguments for and against post-chemotherapy retroperitoneal lymph node dissection (pcRPLND) are presented. There is clear consensus that patient's with residual masses > 1 cm should undergo post-chemotherapy surgery.

publication date

  • November 1, 2011

Research

keywords

  • Lymph Node Excision
  • Neoplasm, Residual
  • Neoplasms, Germ Cell and Embryonal

Identity

Scopus Document Identifier

  • 81055149842

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2011.05.018

PubMed ID

  • 22078409

Additional Document Info

volume

  • 29

issue

  • 6